Home › StemCells, Inc. Acquires Seminal Neural Stem Cell Patent Portfolio
 

Keywords :   


StemCells, Inc. Acquires Seminal Neural Stem Cell Patent Portfolio

2013-10-30 05:24:33| drugdiscoveryonline News Articles

StemCells, Inc. (Nasdaq:STEM) today announced the acquisition of a portfolio of issued US and Canadian patents to which it had previously held an exclusive worldwide license

Tags: cell portfolio stem patent

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news
»
21.09Atlantic Tropical Weather Outlook
21.09Eastern North Pacific Tropical Weather Outlook
20.09Labelexpo Americas highlights, Maxcess announces acquisition and more
20.09September Cattle on Feed as expected
20.09USDA announces major investment in meat and poultry processing
20.09Atlantic Tropical Weather Outlook
20.09Eastern North Pacific Tropical Weather Outlook
20.09This weeks lesson: Weaning matters in the cattle market
More »